Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Leo Ehrlich currently holds 7,835,002 shares of Innovation Pharmaceuticals Inc. (IPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leo Ehrlich has been a net neutral trader of IPIX stock. They have purchased $0 and sold $0 worth of shares.
Leo Ehrlich's most recent insider trade was on Dec 28, 2020, when they sold 7,835,002 shares at $0.21 per share.
Leo Ehrlich serves as Executive at Innovation Pharmaceuticals Inc. (IPIX). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Leo Ehrlich holds the position of Executive at Innovation Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Leo Ehrlich has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Leo Ehrlich was on Dec 28, 2020, when they sold $1.6M worth of IPIX shares. This transaction involved 7,835,002 shares at $0.21 per share.
Leo Ehrlich currently owns 7,835,002 shares of Innovation Pharmaceuticals Inc. (IPIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Leo Ehrlich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Leo Ehrlich has 10 Form 4 filings on record as an insider at Innovation Pharmaceuticals Inc..
Set alerts for Leo Ehrlich and 40,000+ other insiders.